Paul H Edelstein

16PUBLICATIONS
42CO-AUTHORS
Medical bacteriologyMedical mycologyEpigenetics (incl. genome methylation and epigenomics)Medical biotechnology diagnostics (incl. biosensors)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 23, 2025
Structural and functional analysis of the Mycobacterium tuberculosis MmpS5L5 efflux pump presages increased bedaquiline resistance.

Adam J Fountain, Jan Böhning, Stephen H McLaughlin

|Jul 16, 2025
Structural and functional analysis of the Mycobacterium tuberculosis MmpS5L5 efflux pump presages a pathway to increased bedaquiline resistance.

Adam J Fountain, Jan Böhning, Stephen H McLaughlin

|Apr 17, 2025
Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to increase bedaquiline activity.

Adam J Fountain, Natalie J E Waller, Chen-Yi Cheung

|Apr 16, 2024
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute.

Navaneeth Narayanan, Amy J Mathers, Eric Wenzler

|Nov 20, 2023
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.

Chandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar

|Feb 10, 2023
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance.

M Alexandra Lake, Kristin N Adams, Feilin Nie

Pageof 3

Frequent Collaborators

9 joint publications

Lalita Ramakrishnan

4 joint publications

Laura Whitworth

3 joint publications

Roger Sewell

2 joint publications

Ben F Luisi